Nanion 运营日志

 

02.06.2020: 新发表论文预览 - 内溶酶体离子通道有可能成为新冠病毒的致命弱点吗?

内溶酶体离子通道有可能成为 SARS-CoV2 (新型冠状病毒)的致命弱点吗?

Abstract

The ongoing SARS-CoV2 outbreak has developed into a global pandemic. Despite previous outbreaks of SARS-CoV and the related MERS-CoV in recent years, neither a vaccine nor any other medication for an effective treatment are currently available. Endo-lysosomal two-pore cation channels have now emerged as potential novel targets for SARS-CoV treatment.

Download the Publication


你是否知道:离子通道及其在呼吸系统疾病靶标中的作用

2019年底出现SARS-CoV-2(新型冠状病毒)大流行,再加上持续的季节性和大流行性流感病毒的感染,已经给全球范围内的全球公共卫生和卫生系统造成了严重的影响。为了阻止这种流行病并挽救生命,迫切需要有效对抗这些病毒的抗病毒药和疫苗。

许多病毒孔蛋白和离子通道参与了病毒感染和呼吸系统疾病。
Click here for a detailed look and references, inclusive of our latest application notes available for download - dealing with P2X3 and Chronic Cough

返回总览

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.